EMCDDA Home
  • EN
Search

Harm reduction overview for Cyprus

Map of Cyprus

1. National context

The Cyprus Anti-Drugs Council coordinates the development of strategies to reduce drug-related harm. The main actors responsible for organising and implementing harm reduction programmes include the various departments of the Ministry of Health, such as the National AIDS Programme and the Mental Health Services. A reparative law was passed in 2010 that declassified the provision and supply of syringes and needles by health professionals to injecting drug users as an offence.

A low-threshold harm reduction programme at the Multi-Intervention Center in Nicosia offers hepatitis vaccination, testing and counselling, safer use education and psychoeducation, and sterile injecting equipment provision to people who inject drugs. However, the latter service was not used by clients in 2013. Syringes are available for purchase in all pharmacies. Other harm reduction measures that are provided by all governmental and some non-governmental treatment programmes include: (i) vaccinations and testing for infectious diseases with further referral for treatment; (ii) psychoeducation; and (iii) medical care whenever necessary.

It is notable that the National Action Plan 2013–16 aims to broaden further the actions in the area of harm reduction, including the setting up of a street work programme and the distribution of condoms and other safe sex materials and syringes, including in the prison setting. Programmes for high-risk groups, and for bar staff in the context of recreational nightlife training activities, are also being implemented.

top of page

2. Responses to prevent and reduce drug-related infectious diseases

Needle and syringe programmes Country  data
Availability of  NSP programmes  Rare
% NSP availability at NUTS3  10 %
Drug use equipment distributed at specialised drug agencies (standard prevention material)
availability of alcohol pads  No
availability of dry wipes  No
availability of containers  No
availability of water  No
availability of condoms  No
availability of foil  No

Sources:

Structured questionnaire 'Prevention and reduction of health-related harm associated with drug use' (SQ23/29), submitted in 2014.
For an explanation of terms used, see the definitions of terms.
Availability expert rating scale:

  • Full – nearly all persons in need would obtain it.
  • Extensive – a majority but not nearly all of them would obtain it.
  • Limited – more than a few but not a majority of them would obtain it.
  • Rare – just a few of them would obtain it.
Testing, vaccination and treatment of infections Country  data
Availability of Hepatitis C testing in the community  Extensive
Availability of universal hepatitis B immunization programme  No
Hepatitis B vaccination programme specific for high risk groups  No
ARV treatment of HIV infection Extensive

Sources:

Structured questionnaire 'Prevention and reduction of health-related harm associated with drug use' (SQ23/29), submitted in 2014.
Availability expert rating scale:

  • Full – nearly all persons in need would obtain it.
  • Extensive – a majority but not nearly all of them would obtain it.
  • Limited – more than a few but not a majority of them would obtain it.
  • Rare – just a few of them would obtain it.
Health promotion responses Country  data
Availability of individual counselling programmes  Limited
Availability of programmes for practical advice and training on 'safer use/safer injecting'  Rare
Involvement of peer educators in the response to infectious diseases prevention  No

Sources:

Structured questionnaire 'Prevention and reduction of health-related harm associated with drug use' (SQ23/29), submitted in 2014.
Availability expert rating scale:

  • Full – nearly all persons in need would obtain it.
  • Extensive – a majority but not nearly all of them would obtain it.
  • Limited – more than a few but not a majority of them would obtain it.
  • Rare – just a few of them would obtain it.

Drug Treatment

See the country specific treatment profile.

top of page

3. Responses to prevent and reduce drug-related deaths

Availability of drug-related death responses in the community Country  data
Availability of overdose information materials  n.Av.
Availability of individual overdose risk assessment (provided by trained drugs or health workers)  n.Av.
Availability of overdose response training  n.Av.

Sources:

Structured questionnaire 'Prevention and reduction of health-related harm associated with drug use' (SQ23/29), submitted in 2014.
Availability expert rating scale:

  • Full – nearly all persons in need would obtain it.
  • Extensive – a majority but not nearly all of them would obtain it.
  • Limited – more than a few but not a majority of them would obtain it.
  • Rare – just a few of them would obtain it.
Availability of drug consumption rooms Country  data
Number of facilities n.av.
Number of cities n.av.
Number of consumptions per year n.av.

Sources:

Structured questionnaire 'Prevention and reduction of health-related harm associated with drug use' (SQ23/29), submitted in 2014.
N.Av. stands for ‘The intervention is not available in the country’.

top of page

4. Responses to prevent and reduce drug-related harms in recreational settings

Provision of specific responses implemented in night clubs and festivals Free, accessible, cold water Immediate First Aid ‘Chill out’ rooms Information material Outreach work Amnesty bins
Night clubs  Limited  Limited  Limited  Limited  Limited  Does not exist
Festivals  Rare  Rare  Limited  Limited  Rare  Does not exist

Sources:

Structured questionnaire 'Prevention and reduction of health-related harm associated with drug use' (SQ23/29), submitted in 2011.
Provision expert rating scale:

  • Full – in nearly all night clubs/festivals.
  • Extensive – a majority of night clubs/festivals provide the intervention (but not nearly all of them).
  • Limited – more than a few night clubs/festivals provide the intervention (but not a majority of them).
  • Rare – just a few night clubs/festivals provide the intervention.

top of page

5. References and links

Related EMCDDA resources

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Monday, 01 June 2015